Catalyst Pharmaceuticals (CPRX) Stock Price & Financial Analysis
Catalyst Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Catalyst Pharmaceuticals
What is the current stock price for CPRX?
As of the latest trading session, CPRX stock trades at $24.69. The 52-week range is $19.05–$26.58, with a day range of $24.38–$24.79.
What is the P/E ratio for CPRX?
Catalyst Pharmaceuticals's trailing P/E ratio is 14.7, meaning investors pay $14.7 for every $1 of annual earnings. The forward P/E is 11.3, reflecting analyst expectations for future earnings. Catalyst Pharmaceuticals operates in the Healthcare sector.
Does CPRX pay dividends?
Catalyst Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CPRX?
Based on 1 analyst, the consensus for CPRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of CPRX?
Catalyst Pharmaceuticals's market capitalization is $3.14B, classifying it as a mid-cap company. Catalyst Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.